EUVIMEDEUVIMED entdecken
Multizentrische StudieLeitlinieOpen Access · CC BY 4.0

Assessment of Guideline-Directed Medical Therapy Optimization Scores and Readmission Risk in Heart Failure With Reduced Ejection Fraction

Hanna Jensen, Max Staskauskas, Sara Strome, Jethro Pobre, Nghi Le, Cameryn Nakamura, Mina Fahmy, Benjamin Dang, Yvette Hellier, Jaekyu Shin, Tiffany K Pon, Trina Huynh und 5 weitere

Annals of Pharmacotherapy · 2025

DOI: 10.1177/10600280251387249 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Hanna Jensen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, UC San Diego Health, San Diego, CA, USA. Hauptthemen laut MEDLINE: Heart Failure, Patient Readmission, Stroke Volume. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American College of Clinical Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure with reduced ejection fraction carries high morbidity and mortality. Guideline-directed medical therapy (GDMT) improves outcomes, yet real-world use is often suboptimal. Multiple scoring tools quantifying GDMT optimization have been developed to identify areas of improvement, including GDMT count, Optimal Medical Therapy (OMT), modified OMT (mOMT), and Kansas City Medical Optimization (KCMO) scores. Their clinical utility in predicting readmissions is uncertain.

Objective

To evaluate the association between four GDMT scoring systems and 30- and 90-day heart failure (HF) readmissions.

Methods

This multi-center, retrospective cohort study included adults with a left-ventricular ejection fraction ≤40% hospitalized for HF across five academic medical centers between February 2021 and July 2023. Patients discharged on ≥1 GDMT class with ≥1 healthcare encounter within 90 days were included. GDMT scores were calculated at discharge, and their associations with 30- and 90-day HF readmissions were analyzed using mixed-effects Cox proportional hazards models adjusted for clinical covariates.

Results

Among 544 patients, 13.1% experienced 30-day and 26.8% experienced 90-day HF readmissions. At 30 days, no GDMT score was significantly associated with readmission. At 90 days, higher OMT (hazard ratios [HR]: 0.93, 95% CI: 0.86-0.99) and mOMT (HR: 0.94, 95% CI: 0.88-0.99) scores were associated with lower readmission risk, whereas GDMT count and KCMO scores were not. Patients on minimal GDMT regimens contributed disproportionately to 90-day readmissions. Conclusion and Relevance: In this multi-center cohort, OMT and mOMT scores, but not GDMT count or KCMO, were associated with 90-day HF readmissions. Findings highlight the potential utility of simpler GDMT scoring systems while underscoring the need for refined tools incorporating dose intensity, class-specific weighting, and longitudinal therapy to better guide optimization efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailurePatient ReadmissionStroke VolumeHumansMaleFemaleRetrospective StudiesAgedMiddle AgedPractice Guidelines as TopicAged, 80 and over

Stichwörter der Autor:innen

guideline-directed medical therapyheart failurehospital readmissionscore

Autor:innen und Institutionen

  • Department of Pharmacy, UC San Diego Health, San Diego, CA, USA.
  • UC San Francisco Health, San Francisco, CA, USA.
  • UC Davis Medical Center, Sacramento, CA, USA.
  • Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA.
  • San Francisco School of Pharmacy, University of California, San Francisco, CA, USA.
  • Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.

ORCID-Profile: Andrew Willeford

Förderung

  • American College of Clinical Pharmacy

Zitieren

APA

Jensen, H., Staskauskas, M., Strome, S., Pobre, J., Le, N., Nakamura, C., Fahmy, M., Dang, B., Hellier, Y., Shin, J., Pon, T. K., Huynh, T., Namba, J., Wang, L. T., Cadiz, C., Yousif, Z., & Willeford, A. (2025). Assessment of Guideline-Directed Medical Therapy Optimization Scores and Readmission Risk in Heart Failure With Reduced Ejection Fraction. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280251387249

Vancouver

Jensen H, Staskauskas M, Strome S, Pobre J, Le N, Nakamura C, et al. Assessment of Guideline-Directed Medical Therapy Optimization Scores and Readmission Risk in Heart Failure With Reduced Ejection Fraction. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280251387249

BibTeX
@article{Jensen2025,
  author = {Jensen, Hanna and Staskauskas, Max and Strome, Sara and Pobre, Jethro and Le, Nghi and Nakamura, Cameryn and Fahmy, Mina and Dang, Benjamin and Hellier, Yvette and Shin, Jaekyu and Pon, Tiffany K and Huynh, Trina and Namba, Jennifer and Wang, Louise T and Cadiz, Christine and Yousif, Zaid and Willeford, Andrew},
  title = {Assessment of Guideline-Directed Medical Therapy Optimization Scores and Readmission Risk in Heart Failure With Reduced Ejection Fraction},
  journal = {Annals of Pharmacotherapy},
  year = {2025},
  doi = {10.1177/10600280251387249}
}
Kostenlos starten →